MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

01 Oct 2024 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release about Sun Pharma entering into a global exclusive commercialization, license, and supply agreement for commercializing the specialty product FIBROMUN with Philogen S.p.A, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1781.00
Dr. Reddys Labs. 1200.30
Cipla 1335.00
Lupin 2014.00
Zydus Lifesciences 1141.80
View more..